• Nuclear cGAS Suppresses L1 Retrotransposition via CHK2-TRIM4

  2026-06-04

  The referenced study uncovers a novel nuclear role of cGAS in repressing LINE-1 (L1) retrotransposition through a CHK2-dependent pathway that enhances TRIM41-mediated degradation of the L1-encoded ORF2p protein. These findings illuminate a posttranslational genome-protection mechanism, with significant implications for DNA damage response, aging, and cancer research.

• 5X Protein Loading Buffer (Reducing): Technical SDS-PAGE Use

  2026-06-04

  5X Protein Loading Buffer (Reducing) addresses the need for consistent protein denaturation and disulfide bond reduction during SDS-PAGE. It is intended for workflows requiring accurate protein separation by molecular weight under reducing conditions, and should not be used for analyses of native protein structure or non-reducing applications.

• FXR Protein LLPS Drives β-Coronavirus Replication Organelle

  2026-06-03

  This study uncovers how fragile X–related (FXR) proteins, via liquid–liquid phase separation (LLPS), orchestrate the clustering of double-membrane vesicles (DMVs) essential for β-coronavirus proliferation. The findings reveal a novel host-pathogen interaction that enables efficient viral replication and highlight new opportunities for investigating viral organelle dynamics.

• Bile Acid Metabolism Subtypes and Prognostic Markers in Colo

  2026-06-03

  Feng et al. conducted an integrative analysis linking bile acid metabolism with immune microenvironment subtypes in colorectal cancer. Their identification of CLCA1, UGT2A3, and ZG16 as markers of immune dysfunction and prognosis offers new molecular targets for patient stratification and therapeutic research.

• LMO2–LDB1 Complex Drives AML Progression via Transcriptional

  2026-06-02

  This study demonstrates that the interaction between LMO2 and LDB1 forms a key oncogenic complex essential for the proliferation and survival of acute myeloid leukemia (AML) cells. The findings highlight LDB1 as a potential molecular target in AML therapy and provide mechanistic insights into transcriptional regulation underlying leukemogenesis.

• EdU Imaging Kits (HF594): Practical Guide for DNA Synthesis

  2026-06-02

  EdU Imaging Kits (HF594) provide a robust, antibody-free approach for detecting DNA synthesis and quantifying cell proliferation using 5-ethynyl-2’-deoxyuridine incorporation. They are optimal for applications requiring high sensitivity and minimal sample disruption, such as precise cell cycle analysis or flow cytometry. These kits are not intended for live-cell imaging or applications where copper-based reagents may interfere with downstream assays.

• IMPDH Inhibition Impairs PEDV Replication via Nucleotide Met

  2026-06-01

  This study uncovers how porcine epidemic diarrhea virus (PEDV) manipulates host guanine nucleotide biosynthesis by targeting the IMPDH enzyme to facilitate its replication. Pharmacological inhibition or genetic knockdown of IMPDH significantly reduces PEDV RNA and viral titers, positioning IMPDH as a promising host-directed antiviral target.

• CLK2-Driven Platinum Resistance Mechanisms in Ovarian Cancer

  2026-06-01

  This study unveils how Cdc2-like kinase 2 (CLK2) promotes platinum resistance in ovarian cancer by enhancing BRCA1-mediated DNA repair. These findings clarify a previously unknown resistance pathway and inform future strategies for overcoming chemoresistance in BRCA-associated cancer research.

• D-Luciferin (Potassium Salt): Advancing Translational Oncolo

  2026-05-31

  This thought-leadership article explores how D-Luciferin (potassium salt), a high-purity bioluminescence imaging substrate from APExBIO, is revolutionizing translational cancer research. By bridging mechanistic insight with practical strategy, we illustrate its unique value in tracking tumor biology and therapeutic response—especially in the context of emerging molecular targets such as CDCA5 in clear cell renal cell carcinoma. We integrate recent evidence, comparative benchmarks, and workflow recommendations, offering actionable guidance for translational researchers navigating the next generation of in vivo and in vitro studies.

• Zosuquidar (LY335979): Advanced P-gp Inhibition in MDR Model

  2026-05-30

  Zosuquidar (LY335979) 3HCl from APExBIO revolutionizes drug resistance research by enabling precise, selective inhibition of P-glycoprotein (P-gp) in both in vitro and in vivo cancer models. This guide demystifies experimental workflows, highlights data-driven protocol optimizations, and delivers actionable troubleshooting for overcoming multidrug resistance (MDR) in oncology.

• Cy3-UTP for High-Sensitivity RNA Labeling and Live-Cell Imag

  2026-05-29

  Harness the photostability and brightness of Cy3-UTP for advanced RNA labeling in fluorescence imaging and RNA-protein interaction studies. Learn how this Cy3-modified uridine triphosphate from APExBIO streamlines workflows, enhances data clarity, and overcomes common experimental pitfalls.

• Zosuquidar (LY335979): Precision Reversal of Multidrug Resis

  2026-05-29

  Zosuquidar (LY335979) 3HCl enables robust, selective inhibition of P-glycoprotein to overcome multidrug resistance in cancer models and enhances chemotherapy efficacy without altering drug pharmacokinetics. This article details applied workflows, troubleshooting insights, and innovative protocol enhancements for leveraging Zosuquidar in MDR research.

• Cy3-UTP: Precision RNA Labeling for Live-Cell Imaging & Assa

  2026-05-28

  Cy3-UTP empowers scientists to generate highly photostable, fluorescently labeled RNA for advanced imaging, RNA-protein interaction studies, and real-time chromatin dynamics. Its robust incorporation and bright signal enable direct visualization workflows that surpass traditional labeling methods, aligning with breakthroughs in multiplexed genomic imaging.

• Optimizing mRNA-LNP Assays with EZ Cap™ Firefly Luciferase m

  2026-05-28

  Explore how Firefly Luciferase mRNA with 5-moUTP modification—featuring advanced 5' capping and poly(A) tail engineering—enables robust, immune-silent bioluminescent assays. This article uniquely bridges practical protocol design with the latest microfluidic LNP manufacturing advances.

• Methylation Pathways in Neurological Disorders: Insights fro

  2026-05-27

  This review by Bottiglieri et al. synthesizes evidence on the neurochemical and clinical significance of methylation—especially S-adenosylmethionine (SAMe)—in neurological and psychiatric conditions. The paper highlights the interdependence of SAMe, folate, and vitamin B12 metabolism, and discusses how disruptions in these pathways may underlie disorders such as depression, dementia, and methotrexate-induced encephalopathy.

16518 records 1/1102 page Next 12345 下5页 Last page